About Benralizumab (FASENRA)
            
            Class: | Monoclonal antibody (anti-IL-5 receptor alpha)  
Use: | Indicated for the treatment of severe asthma with eosinophilic phenotype in patients aged 12 years and older, and for the treatment of eosinophilic granulomatosis with polyangiitis (EGPA) in adults.  
Adult dose: | 30 mg administered subcutaneously every 4 weeks for the first 3 doses, then every 8 weeks thereafter.  
Pediatric dose: | Not established for patients under 12 years of age; safety and efficacy in this population have no
         
        
            
                
                
                    
                        Drug Class
                    
                    Monoclonal antibody (anti-IL-5 receptor alpha)
                 
                
                
                    
                        Uses & Indications
                    
                    Indicated for the treatment of severe asthma with eosinophilic phenotype in patients aged 12 years and older, and for the treatment of eosinophilic granulomatosis with polyangiitis (EGPA) in adults.
                 
                
                
                    
                        Storage Requirements
                    
                    Store in the refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze. Protect from light.
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: AstraZeneca AB, SWEDEN
                    
                    
                    Package Size
                    1 Pre-Filled Syringe
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 12103.00
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        30 mg administered subcutaneously every 4 weeks for the first 3 doses, then every 8 weeks thereafter.
                    
                    
                        Pediatric Dose
                    
                    
                        Not established for patients under 12 years of age; safety and efficacy in this population have not been determined.
                    
                 
                
                
                    
                        Side Effects
                    
                    Common side effects include headache, injection site reactions, pharyngitis, and fever.
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Hypersensitivity to benralizumab or any component of the formulation; caution in patients with a history of hypersensitivity reactions.
         
        
        
            
                Important Warnings
            
            Risk of serious allergic reactions; monitor for signs of anaphylaxis. Not for the treatment of acute asthma symptoms or exacerbations.
         
        
        
        
        
        
            
                Related Medicines in Same Category
            
            
                See also: Other Monoclonal antibody (anti-IL-5 receptor alpha) medicines available in UAE pharmacies
            
            
            
                Benralizumab
            
            
            
                Benralizumab
            
            
         
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.